Physician profile
Marco Rocha
NPI 1689921405
$590.37
in general payments reported to CMS, 2019-2025
12 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.21 · 2022: $49.32 · 2023: $57.25 · 2024: $79.75 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $149.53 | 2025 | |
| Depuy Synthes Sales INC. | $122.98 | 2022-2025 | Monovisc, Orthovisc, Peak |
| Janssen Biotech, INC. | $110.48 | 2025 | Carvykti, Rybrevant |
| Endo USA, INC. | $34.51 | 2025 | Aveed, Xiaflex |
| Antares Pharma, INC. | $32.66 | 2025 | Xyosted |
| Ermi LLC | $28.10 | 2025 | |
| Smith+Nephew, INC. | $24.41 | 2024 | Pico 14 |
| Kowa Pharmaceuticals America, INC. | $20.96 | 2022 | |
| Bioventus LLC | $18.72 | 2025 | Xcell |
| Electronic Waveform Lab, INC. | $16.88 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $15.93 | 2024 | Exparel, Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $15.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Rocha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.